CureVac N.V. (CVAC)

CureVac Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	416.09	481.75	402.45	495.8	811.46	1,323
Cash & Short-Term Investments	416.09	481.75	402.45	495.8	811.46	1,323
Cash Growth	-24.47%	19.70%	-18.83%	-38.90%	-38.65%	4210.37%
Accounts Receivable	19.6	14.08	14.33	6.3	18.5	1.01
Other Receivables	-	2.76	2.76	2.71	-	0.81
Total Trade Receivables	19.6	16.84	17.08	9	18.5	1.82
Inventory	0.54	0.54	24.8	23.99	56.16	14.53
Other Current Assets	436.88	27.28	34.04	55.24	53.89	50.91
Total Current Assets	873.11	526.41	478.38	584.03	940.02	1,390
Net Property, Plant & Equipment	235.6	244.65	278.63	241.7	200.39	100.59
Other Intangible Assets	24.68	25.16	28.35	31.78	13.24	14.15
Other Long-Term Assets	5.23	6.61	2.9	2.96	4.59	6.77
Total Assets	1,139	802.83	788.25	860.47	1,158	1,511

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	8.72	17.27	48.03	73.46	127.7	21.69
Current Portion of Leases	4.77	5.32	5.01	4.98	3.47	3.23
Unearned Revenue	0.36	-	44.58	34.76	55.75	157.99
Other Current Liabilities	222.33	49.76	105.77	43.02	170.81	64.72
Total Current Liabilities	236.17	72.35	203.39	156.23	357.73	247.62
Long-Term Debt	-	-	-	-	-	25.19
Long-Term Leases	30.3	33.64	36.82	37.11	25.42	26.85
Other Long-Term Liabilities	0.82	0.23	48.1	133.89	86.61	500.35
Total Long-Term Liabilities	31.22	33.87	84.92	170.99	112.03	552.39
Total Liabilities	267.39	106.22	288.31	327.22	469.77	800.01

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	27.02	26.92	26.88	23.4	22.45	21.66
Treasury Stock	-	-	-	-1.48	-5.82	-
Additional Paid-in Capital	-	-	2,056	1,817	1,729	1,335
Accumulated Other Comprehensive Income	-0.31	0.04	-0.07	-0.14	-0.03	0.06
Retained Earnings	-1,242	-1,404	-1,583	-1,306	-1,057	-645.07
Shareholders' Equity	871.23	696.61	499.94	533.25	688.48	711.35
Total Liabilities & Equity	1,139	802.83	788.25	860.47	1,158	1,511

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	35.07	38.97	41.82	42.09	28.89	55.28
Net Cash (Debt)	381.02	442.78	360.63	453.71	782.57	1,267
Net Cash Growth	-25.40%	22.78%	-20.52%	-42.02%	-38.25%	-
Net Cash Per Share	-	1.97	1.63	2.40	4.21	9.59
Book Value	871.23	696.61	499.94	533.25	688.48	711.35
Book Value Per Share	-	3.09	2.26	2.82	3.70	5.38
Tangible Book Value	846.55	671.45	471.59	501.48	675.24	697.2
Tangible Book Value Per Share	-	2.98	2.13	2.65	3.63	5.27

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Sep 30, 2025

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error